223 related articles for article (PubMed ID: 10781584)
21. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension.
O'Connor DT; Kailasam MT; Kennedy BP; Ziegler MG; Yanaihara N; Parmer RJ
J Hypertens; 2002 Jul; 20(7):1335-45. PubMed ID: 12131530
[TBL] [Abstract][Full Text] [Related]
22. Chromogranin A synthesis and secretion in chromaffin cells.
Eiden LE; Iacangelo A; Hsu CM; Hotchkiss AJ; Bader MF; Aunis D
J Neurochem; 1987 Jul; 49(1):65-74. PubMed ID: 3585342
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation and O-glycosylation sites of bovine chromogranin A from adrenal medullary chromaffin granules and their relationship with biological activities.
Strub JM; Sorokine O; Van Dorsselaer A; Aunis D; Metz-Boutigue MH
J Biol Chem; 1997 May; 272(18):11928-36. PubMed ID: 9115255
[TBL] [Abstract][Full Text] [Related]
24. Chromogranin B: isolation from pheochromocytoma, N-terminal sequence, tissue distribution and secretory vesicle processing.
Gill BM; Barbosa JA; Dinh TQ; Garrod S; O'Connor DT
Regul Pept; 1991 Apr; 33(2):223-35. PubMed ID: 1882087
[TBL] [Abstract][Full Text] [Related]
25. Differential accumulation of catecholamines, proenkephalin- and chromogranin A-derived peptides in the medium after chronic nicotine stimulation of cultured bovine adrenal chromaffin cells.
Watkinson A; O'Sullivan AJ; Burgoyne RD; Dockray GJ
Peptides; 1990; 11(3):435-41. PubMed ID: 2381869
[TBL] [Abstract][Full Text] [Related]
26. Isolation and identification of intact chromogranin A and two N-terminal processing products, vasostatin I and II, from bovine adrenal medulla chromaffin granules by chromatographic and mass spectrometric methods.
Bauer SH; Zhang XY; Liang F; De Potter WP; Claeys M; Przybylski M
Neuropeptides; 1997 Jun; 31(3):273-80. PubMed ID: 9243525
[TBL] [Abstract][Full Text] [Related]
27. Catecholamine release from bovine adrenal chromaffin cells during anoxia or metabolic inhibition.
Dry KL; Phillips JH; Dart AM
Circ Res; 1991 Aug; 69(2):466-74. PubMed ID: 1860185
[TBL] [Abstract][Full Text] [Related]
28. Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension.
Rao F; Wen G; Gayen JR; Das M; Vaingankar SM; Rana BK; Mahata M; Kennedy BP; Salem RM; Stridsberg M; Abel K; Smith DW; Eskin E; Schork NJ; Hamilton BA; Ziegler MG; Mahata SK; O'Connor DT
Circulation; 2007 May; 115(17):2271-81. PubMed ID: 17438154
[TBL] [Abstract][Full Text] [Related]
29. New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.
Briolat J; Wu SD; Mahata SK; Gonthier B; Bagnard D; Chasserot-Golaz S; Helle KB; Aunis D; Metz-Boutigue MH
Cell Mol Life Sci; 2005 Feb; 62(3):377-85. PubMed ID: 15723172
[TBL] [Abstract][Full Text] [Related]
30. Chromostatin, a 20-amino acid peptide derived from chromogranin A, inhibits chromaffin cell secretion.
Galindo E; Rill A; Bader MF; Aunis D
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1426-30. PubMed ID: 1996343
[TBL] [Abstract][Full Text] [Related]
31. Granins and catecholamines: functional interaction in chromaffin cells and adipose tissue.
Borges R; Dominguez N; Smith CB; Bandyopadhyay GK; O'Connor DT; Mahata SK; Bartolomucci A
Adv Pharmacol; 2013; 68():93-113. PubMed ID: 24054141
[TBL] [Abstract][Full Text] [Related]
32. The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364). Properties and function.
Mahata SK; Mahata M; Livsey Taylor CV; Taupenot L; Parmer RJ; O'Connor DT
Adv Exp Med Biol; 2000; 482():263-77. PubMed ID: 11192587
[No Abstract] [Full Text] [Related]
33. Ontogenesis of chromogranin A and B and catecholamines in rat adrenal medulla.
Schober M; Fischer-Colbrie R; Winkler H
Brain Res; 1989 Jan; 478(1):41-6. PubMed ID: 2924120
[TBL] [Abstract][Full Text] [Related]
34. Human chromogranin A. Purification and characterization from catecholamine storage vesicles of human pheochromocytoma.
O'Connor DT; Frigon RP; Sokoloff RL
Hypertension; 1984; 6(1):2-12. PubMed ID: 6693145
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo.
Kennedy BP; Mahata SK; O'Connor DT; Ziegler MG
Peptides; 1998; 19(7):1241-8. PubMed ID: 9786174
[TBL] [Abstract][Full Text] [Related]
36. Catecholamine secretory vesicles. Augmented chromogranins and amines in secondary hypertension.
Takiyyuddin MA; De Nicola L; Gabbai FB; Dinh TQ; Kennedy B; Ziegler MG; Sabban EL; Parmer RJ; O'Connor DT
Hypertension; 1993 May; 21(5):674-9. PubMed ID: 8491501
[TBL] [Abstract][Full Text] [Related]
37. Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin.
Biswas N; Vaingankar SM; Mahata M; Das M; Gayen JR; Taupenot L; Torpey JW; O'Connor DT; Mahata SK
Endocrinology; 2008 Feb; 149(2):749-57. PubMed ID: 17991725
[TBL] [Abstract][Full Text] [Related]
38. Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules.
Strub JM; Goumon Y; Lugardon K; Capon C; Lopez M; Moniatte M; Van Dorsselaer A; Aunis D; Metz-Boutigue MH
J Biol Chem; 1996 Nov; 271(45):28533-40. PubMed ID: 8910482
[TBL] [Abstract][Full Text] [Related]
39. Different processing of chromogranin B into GAWK-immunoreactive fragments in the bovine adrenal medulla and pituitary gland.
Iguchi H; Natori S; Kato K; Nawata H; Chrétien M
Life Sci; 1988; 43(23):1945-52. PubMed ID: 3200116
[TBL] [Abstract][Full Text] [Related]
40. Catestatin--a novel neuropeptide in carcinoid tumors of the appendix.
Prommegger R; Ensinger C; Adlassnig C; Vaingankar S; Mahata SK; Marksteiner J; Margreiter R
Anticancer Res; 2004; 24(1):311-6. PubMed ID: 15015613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
